Company Quick10K Filing
Mellanox Technologies
10-K 2019-12-31 Filed 2020-02-20
10-Q 2019-09-30 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-01
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-02-21
10-Q 2018-09-30 Filed 2018-11-02
10-Q 2018-06-30 Filed 2018-08-03
10-Q 2018-03-31 Filed 2018-05-04
10-K 2017-12-31 Filed 2018-02-16
10-Q 2017-09-30 Filed 2017-11-03
10-Q 2017-06-30 Filed 2017-08-04
10-Q 2017-03-31 Filed 2017-05-05
10-K 2016-12-31 Filed 2017-02-17
10-Q 2016-09-30 Filed 2016-11-04
10-Q 2016-06-30 Filed 2016-07-29
10-Q 2016-03-31 Filed 2016-04-29
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-09-30 Filed 2015-10-30
10-Q 2015-06-30 Filed 2015-07-31
10-Q 2015-03-31 Filed 2015-05-01
10-K 2014-12-31 Filed 2015-03-02
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-11
10-Q 2014-03-31 Filed 2014-05-02
10-K 2013-12-31 Filed 2014-02-28
10-Q 2013-09-30 Filed 2013-11-01
10-Q 2013-06-30 Filed 2013-08-02
10-Q 2013-03-31 Filed 2013-05-03
10-K 2012-12-31 Filed 2013-02-25
10-Q 2012-09-30 Filed 2012-11-02
10-Q 2012-06-30 Filed 2012-08-03
10-Q 2012-03-31 Filed 2012-05-04
10-K 2011-12-31 Filed 2012-02-28
10-Q 2011-09-30 Filed 2011-11-04
10-Q 2011-06-30 Filed 2011-08-04
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-03-07
10-Q 2010-09-30 Filed 2010-11-04
10-Q 2010-06-30 Filed 2010-08-04
10-Q 2010-03-31 Filed 2010-05-06
10-K 2009-12-31 Filed 2010-03-05
8-K 2020-04-27
8-K 2020-04-23
8-K 2020-04-16
8-K 2020-01-29
8-K 2019-12-19
8-K 2019-10-30
8-K 2019-07-25
8-K 2019-07-24
8-K 2019-06-20
8-K 2019-05-23
8-K 2019-04-16
8-K 2019-03-10
8-K 2019-01-30
8-K 2019-01-03
8-K 2018-10-24
8-K 2018-07-25
8-K 2018-07-17
8-K 2018-07-09
8-K 2018-06-19
8-K 2018-05-24
8-K 2018-05-17
8-K 2018-04-23
8-K 2018-04-17
8-K 2018-04-17
8-K 2018-03-15
8-K 2018-03-12
8-K 2018-03-07
8-K 2018-02-20
8-K 2018-01-23
8-K 2018-01-18
8-K 2018-01-17
8-K 2018-01-09
8-K 2017-12-31

Mellanox Technologies Financials

MLNX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash73196234260320398420396358295327336340351386429464486511262276292329325310346274287283351439552609741
Accounts Receivable46464847555359596874716569736556616584105117133142126150134154143156143151172200203
Inventory1518253231344346363236393739445163636272656266757262657094105104969085
PP&E223071768297111106113119127133137149161172189202212224242253267282289296215223226230228236241248
Assets3784985305636327267717657697878078128168428638999639871,0531,3981,4081,4351,4741,4791,4671,4711,4021,4281,4501,5041,5871,7581,8221,950
Accounts Payable18263032354037262625302930374040504245485550606359425964717370637484
Long-Term Debt2752782492422232131987334000
Liabilities69718893114135143128121126141140140148161167191178187507494479498485462434344301288270286363359398
Stockholders' Equity3084274424705185926286376486616666726766957027327728098678929149569769941,0051,0371,0571,1271,1621,2341,3021,3951,4631,552
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue63687389154156122839810410699103121142147163171177197215224222189212226238251268279305310335
Cost of Revenue2224262946483929323737343440414147495270807874647377858910496108110118
Gross Profit414447601081088354666768656881101106116122125126135146148124139148152162165184197200218
R&D2423252938363638394448485054575863666671828486889291948687939299107
SG&A151515182223232427282927282830323436405946484948515153565950595961
Tax1111016121-01-0-119211-232013-222-5-26-04466
Net Income2
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating2224597425-7111631117174546412935494549543565547668859130
Cash Investing-42-101-55-74-519-13-112-6-32-11-14-50-42-373786-477-93-48-46-231-0-43-76-85-87-140
Cash Financing479145627160817272283-6-9-11-10-6-27-311115-19